Quantifying Uterine Elastography in Menstruating Women
This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using sh
| Condition(s) | Infertility (IVF Patients), Infertility Assisted Reproductive Technology |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using shear wave elastography to diagnose and predict outcomes for patients seeking fertility treatment might be established. |
| Who can participate | Group A Inclusion Criteria: * Patients with normal menstrual cycles lasting 28-34 days * Patients with normal uterine anatomy * Patients with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries * Patient who have no known infertility (i.e. women who have not tried to conceive) Exclusion Criteria: * BMI ≥ 35 * Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication. * History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy) * History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, remov |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Reproductive Medicine Associates of New Jersey |
| Locations | Basking Ridge, New Jersey, United States |
| Start date | 2025-02-06 |
| NCT ID | NCT06816381 |
| Official listing | https://clinicaltrials.gov/study/NCT06816381 |